Cargando…

MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature

BACKGROUND: In around 20% of cases, myelin oligodendrocyte glycoprotein (MOG) immunoglobulin (IgG)-associated encephalomyelitis (MOG-EM; also termed MOG antibody-associated disease, MOGAD) first occurs in a postinfectious or postvaccinal setting. OBJECTIVE: To report a case of MOG-EM with onset afte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jarius, S., Bieber, N., Haas, J., Wildemann, B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219396/ https://www.ncbi.nlm.nih.gov/pubmed/35737110 http://dx.doi.org/10.1007/s00415-022-11194-9

Ejemplares similares

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
por: Jarius, S., et al.
Publicado: (2018)

MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020)

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
por: Spadaro, Melania, et al.
Publicado: (2015)

Peripherally derived macrophages as major phagocytes in MOG encephalomyelitis
por: Kwon, Young Nam, et al.
Publicado: (2019)

Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
por: Borisow, Nadja, et al.
Publicado: (2018)

MOG-associated encephalitis following SARS-COV-2 infection
por: Peters, John, et al.
Publicado: (2021)

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature
por: Jarius, S., et al.
Publicado: (2018)

Acute disseminated encephalomyelitis associated with anti-myelin oligodendrocyte glycoprotein (MOG-IGG) antibody in a patient with recent vaccination against SARS-CoV-2
por: Simone, Anna Maria, et al.
Publicado: (2021)

Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques
por: Fovet, Claire-Maëlle, et al.
Publicado: (2019)

Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
por: Chiuso-Minicucci, Fernanda, et al.
Publicado: (2015)

Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2): A follow‐up study
por: Doubrovinskaia, Sofia, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: O’Leary, Valerie Bríd, et al.
Publicado: (2020)

Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis
Publicado: (2015)

Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model
por: das Neves, Sofia P., et al.
Publicado: (2018)

‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook
por: Jarius, S., et al.
Publicado: (2015)

MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review
por: Matsumoto, Yuki, et al.
Publicado: (2022)

The history of neuromyelitis optica. Part 2: ‘Spinal amaurosis’, or how it all began
por: Jarius, S., et al.
Publicado: (2019)

ADEM anti-MOG antibody-positive after SARS-CoV2 vaccination
por: Mumoli, Laura, et al.
Publicado: (2021)

Is there a correlation between MOG‐associated disorder and SARS‐CoV‐2 infection?
por: Mariotto, Sara, et al.
Publicado: (2022)

‘Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC
por: Jarius, S., et al.
Publicado: (2015)

COVID-19-related severe MS exacerbation with life-threatening Takotsubo cardiomyopathy in a previously stable patient and interference of MS therapy with long-term immunity against SARS-CoV-2
por: Wildemann, Brigitte, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update
por: Pal, Mahendra, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (Coronaviridae)
por: Peiris, Malik
Publicado: (2021)

AZD-1222: Acute disseminated encephalomyelitis anti-MOG antibody‑positive: case report
Publicado: (2022)

Clinical, radiological, therapeutic and prognostic differences between MOG-seropositive and MOG-seronegative pediatric acute disseminated encephalomyelitis patients: a retrospective cohort study
por: Dong, Xueshan, et al.
Publicado: (2023)

Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis
por: Jarius, Sven, et al.
Publicado: (2022)

Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature
por: Fontana, Lauren M., et al.
Publicado: (2020)

Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2
por: Rajasekharan, Sreejith, et al.
Publicado: (2021)

Perspectives on development of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Zhang, Chao, et al.
Publicado: (2020)

Iodine mouthwashes as deterrents against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Blasi, Claudio
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review
por: Feng, Wei, et al.
Publicado: (2020)

Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2)
por: Maveddat, Ashley, et al.
Publicado: (2020)

JMM Profile: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
por: Inglis, Timothy J. J., et al.
Publicado: (2021)

SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2) INFECTION: AN EPIDEMIOLOGICAL REVIEW
por: Buowari, D.Y., et al.
Publicado: (2021)

Experimental Autoimmune Encephalomyelitis Is Successfully Controlled by Epicutaneous Administration of MOG Plus Vitamin D Analog
por: Zorzella-Pezavento, Sofia Fernanda Gonçalves, et al.
Publicado: (2017)

Severe Acute Respiratory Syndrome Coronavirus (SARS, SARS CoV)
por: McFee, R.B.
Publicado: (2020)

Myelinoclastic diffuse sclerosis (Schilder’s disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures
por: Jarius, S., et al.
Publicado: (2019)

Evolutionary study of COVID‐19, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) as an emerging coronavirus: Phylogenetic analysis and literature review
por: Tabibzadeh, Alireza, et al.
Publicado: (2020)

Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment
por: Masuccio, Fabio Giuseppe, et al.
Publicado: (2020)

Seroprevalence of antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) in household dogs in Japan
por: ITO, Genta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_or3lvsi89h9ka8dmb9mjvtraok